Workflow
宠物健康产品
icon
Search documents
跨境电商运营:2024中国宠物产业出海分析报告
Sou Hu Cai Jing· 2025-06-27 13:19
Core Insights - The report highlights the rapid expansion of China's pet industry in the international market, with exports reaching $5.8 billion in 2023 and projected to exceed $6.5 billion in 2024, driven primarily by pet food, which accounts for 55% of exports [1] - The United States remains the largest market for pet products, holding a 40% share of the global pet market, with a household penetration rate of 70% [1][26] - Emerging markets such as Southeast Asia and Latin America show significant growth potential, with Indonesia's pet market expected to grow from $2.3 billion in 2023 to $5.9 billion by 2033 [1][44] Industry Overview - The global pet products market was valued at $261 billion in 2022 and is expected to reach $350 billion by 2027, with a compound annual growth rate (CAGR) of approximately 6.1% [10] - The U.S. pet market is projected to reach $80.69 billion in 2024, with pet food and treats accounting for $64.41 billion of that total [26] - In Europe, the pet market is also substantial, with a total value of approximately €29.2 billion, indicating strong demand for pet products [30] Export Overview - China's pet product exports have shown consistent growth, with a peak of $4.39 billion in 2022, followed by a slight decline to $3.96 billion in 2023 [13] - The main export categories include pet food, toys, clothing, and care products, with a complete supply chain from raw materials to logistics [14] - The U.S., Germany, and the UK are the primary destinations for Chinese pet food exports, with significant growth rates observed in these markets [17] Market Analysis - The North American market is a major driver for pet e-commerce, with platforms like Chewy and PetSmart leading the way [24] - In Europe, there is a strong emphasis on high-quality and natural products, with German platforms like Zooplus setting market trends [24] - The Asia-Pacific region, particularly China, is witnessing rapid growth in pet e-commerce, driven by platforms like JD and Taobao [24] Competitive Landscape - Chinese pet companies possess advantages such as cost efficiency, manufacturing capabilities, product innovation, and e-commerce experience [22] - Challenges include insufficient brand influence, quality control issues, and regulatory barriers in foreign markets [22] - Opportunities arise from the growing global pet market, diverse consumer demands, and the rise of digital marketing [23]
澳大利亚华商:一直视中国为亚太地区重要战略市场
Zhong Guo Xin Wen Wang· 2025-06-26 16:35
Core Viewpoint - Homart Group views China as a key strategic market in the Asia-Pacific region and is increasing its investment in the Chinese market [1][2] Group 1: Company Overview - Homart Group, established in 1992, focuses on the health and nutrition sector and has multiple cGMP-certified production bases in Australia and New Zealand [2] - The company has obtained various international certifications, including TGA, FDA, halal, and organic production [2] - Homart is preparing for a listing on the Australian Securities Exchange to seek broader international cooperation opportunities [2] Group 2: Market Engagement - Homart participated in the 15th China International Health Products Expo, showcasing Australia's latest achievements in health products and promoting deeper cooperation between China and Australia [1] - The expo is a significant platform for the health and nutrition industry in the Asia-Pacific region, attracting global enterprises and professionals [1] - During the expo, Homart engaged in brand exchange sessions and trade matching activities, discussing product compliance, channel cooperation, and market trends with Chinese enterprises and institutions [2] Group 3: Market Trends - The demand for high-quality nutrition and health products in China is continuously growing as the country accelerates its health initiatives [2] - Australia is recognized as a major exporter of health products, possessing advantages in quality regulation and product development [2] - The potential for cooperation between China and Australia in the health sector is increasingly being realized [2]
“硬科技”“好产品”搭桥梁 中国与中东欧国家共建互利合作新范式
Zheng Quan Shi Bao· 2025-05-23 21:16
Group 1 - The Fourth China-Central and Eastern European Countries Expo and International Consumer Goods Expo was held from May 22 to 25 in Ningbo, Zhejiang Province, serving as a high-level economic and cultural event to enhance practical cooperation between China and Central and Eastern European countries [1] - The expo has become an "accelerator" for pragmatic cooperation, focusing on "hard technology" and "good products," with Chinese and Central and Eastern European enterprises exploring multi-layered and multi-field collaborations [1] - A notable exhibit was the large-space VR amusement park from Hungary's VR PARK, which aims to attract Chinese consumers by offering a unique VR experience distinct from common VR setups found in malls [1][2] Group 2 - The large-space VR project is successfully promoted in cities like Ningbo and Yangzhou, with plans to expand to 10 cities this year, targeting the younger generation, particularly Gen Z [2] - The centerpiece of the expo was the HEMEP hybrid multi-engine aircraft, the world's first multi-engine hybrid aircraft developed by Austria's Diamond Aircraft, which has been fully acquired by China's Wan Feng Group [2] - Wan Feng Group aims to become a global leader in general aviation manufacturing, having established four aircraft manufacturing bases and three design and R&D centers worldwide, with services in 90 countries [2] Group 3 - During the expo, a procurement signing event resulted in contracts totaling 2.49 billion yuan, covering various products including minerals, pet health products, and ski equipment [3] - A significant partnership was formed between Ningbo Free Trade Zone and Serbia's Vetplanet, agreeing to import pet health products worth 80 million yuan annually over three years, totaling 240 million yuan [3] - The collaboration is seen as a bright spot in the domestic pet health market, emphasizing the importance of product safety and efficacy, supported by compliance and testing from authoritative institutions [3]